Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDK5 |
| Upstream (Parents) |
|---|
| (<<) GSK3A → CDK5 |
| (<<) HRAS → CDK5 |
| (<<) KLF11 → CDK5 |
| (<<) MIA3 → CDK5 |
| (<<) NUDT6 → CDK5 |
| (<<) PGK1 → CDK5 |
| (<<) SLC29A1 → CDK5 |
| Downstream (Children) |
|---|
| CDK5 → CCL24 (>>) |
| CDK5 → GNB2 (>>) |
| CDK5 → MMP15 (>>) |
| CDK5 → NFKBIE (>>) |
| CDK5 → PIP5K1C (>>) |
| CDK5 → PPP1R11 (>>) |
| CDK5 → PRKCH (>>) |
| CDK5 → RASSF1 (>>) |
| CDK5 → SHFM1 (>>) |
| CDK5 → TINF2 (>>) |
| CDK5 → TK2 (>>) |
| CDK5 → TMEM39B (>>) |
| CDK5 → TRAF6 (>>) |
| CDK5 → VAC14 (>>) |
